Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use

October 6, 2016 updated by: John R Knight, MD, Boston Children's Hospital

Dental and Medical Office Internet/Intranet Motivational Enhancement Therapy to Reduce Teen Tobacco, Alcohol, and Drug Use

The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

We have previously developed and tested in a treatment population a promising MET program for alcohol and drug use. We will broaden the MET intervention to also target tobacco use and convert the new materials into a self-administered format.

Study Type

Interventional

Enrollment (Actual)

121

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Children's Hospital Boston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 21 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 12-21 years old
  • Coming for routine care

Exclusion Criteria:

  • Medically or emotionally unstable day of visit
  • Already receiving behavioral health services
  • Cannot read/understand English
  • Will not be available for post-tests

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Treatment as usual
Participants will receive treatment as usual from their provider.
Experimental: iMET
Participants will receive the iMET intervention.
Behavioral: iMET
Participants will receive the iMET intervention
Experimental: iMET/TE
Participants will receive the iMET intervention and Technological Extenders (TEs).
Behavioral: iMET/TE
Participants will receive the iMET intervention and also receive TEs (Technological Extenders)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Frequency of tobacco, alcohol, marijuana, and other drug use
Time Frame: 3 months, 6 months
3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Rates of initiation and cessation of tobacco, alcohol, marijuana and other drug use
Time Frame: 3 months, 6 months
3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Boston Children's Hospital

Collaborators

Tufts Medical Center
Cambridge Health Alliance
Fallon Clinic
Harvard School of Dental Medicine

Investigators

  • Principal Investigator: John R. Knight, MD, Boston Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

September 1, 2012

Study Completion (Actual)

September 1, 2012

Study Registration Dates

First Submitted

May 20, 2009

First Submitted That Met QC Criteria

May 21, 2009

First Posted (Estimate)

May 22, 2009

Study Record Updates

Last Update Posted (Estimate)

October 7, 2016

Last Update Submitted That Met QC Criteria

October 6, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • iMET RFA-OD-09-003

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drug Abuse

Clinical Trials on iMET

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe